Teladoc Health (NYSE: TDOC) was up in morning trading at the time of writing on Tuesday after the virtual healthcare company announced a collaboration with the tech giant, Microsoft (MSFT). As a part of this partnership, Teladoc will use MSFT’s artificial intelligence (AI) services to automate its clinical documentation in order to reduce the burden on its healthcare staff during virtual exams.
Teladoc will use Microsoft’s AI-powered voice-enabled solution, Nuance Dragon Ambient eXperience, which uses the GPT4 AI service, to automate clinical documentation.
Analysts are cautiously optimistic about TDOC stock with a Moderate Buy consensus rating based on six Buys and 11 Holds.
